Related Experiment Videos
[A high-throughput SNP typing system for genome-wide association studies]
1Laboratory for Cardiovascular Diseases, SNP Research Center, Institute of Physical and Chemical Research (RIKEN), 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|December 6, 2002
Summary
This study presents a new method for whole-genome association studies using single nucleotide polymorphisms (SNPs). The technique significantly reduces the required genomic DNA, making large-scale genetic disease research more feasible with minimal blood samples.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Context:
- Single nucleotide polymorphisms (SNPs) are crucial genetic markers for disease association studies and personalized medicine.
- Whole-genome association studies (WGS) are powerful tools but are limited by the substantial genomic DNA required for SNP genotyping.
- Current genotyping technologies demand impractically large amounts of DNA, hindering large-scale genetic research.
Purpose:
- To develop a practical and efficient method for whole-genome association studies by reducing the amount of genomic DNA needed for SNP genotyping.
- To combine multiplex PCR with the Invader assay and a novel 384-well system to enable high-throughput SNP analysis with minimal DNA input.
Summary:
- A novel method integrating multiplex PCR (using Taq polymerase antibody) and the Invader assay in a 384-well system was developed.
- This approach simultaneously amplifies 96 genomic DNA fragments, requiring only 0.1-0.2 nanograms of DNA per SNP.
- The system enables genome-wide association studies using as little as 5-10 milliliters of blood and can perform up to 450,000 typings daily.
Impact:
- This technology significantly lowers the DNA input requirement for SNP genotyping, overcoming a major bottleneck in WGS.
- It facilitates large-scale genetic association studies, potentially identifying genes linked to common diseases and predicting pharmacological responses.
- The high-throughput capability accelerates the discovery of genetic factors influencing health and disease.